Credits: Canva
Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.
The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.
The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.
The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.
The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.
Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."
The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.
However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.
Credit: AI
As the United States lost its measles elimination status of more than 25 years, Health and Human Services Secretary Robert F. Kennedy Jr. and his long record of challenging established public health norms and policies are being heavily scrutinised.
The US has reported more than 5,700 measles infections and 11 deaths in 2026, amid an alarming decline in childhood vaccination coverage in several states.
A recent Reuters investigation examined how vaccine skepticism and gaps in outbreak response have contributed to the country's measles crisis.
Kennedy, a longtime vaccine skeptic, had made several controversial health claims about several things like removing fluoride in drinking water, promoting raw milk, linking tylenol and autism, COVID-19 and cellphone radiation.Some of his concerns relate to legitimate areas of scientific debate but many others clash with established evidence.
Vaccine-autism controversy dates back to a 1998 study which suggested a link between the MMR vaccine and autism. The paper was subsequently retracted.But Kennedy has been a long-time skeptic of vaccines, questioning their efficacy and safety on multiple occasions.
He has repeatedly argued that vaccines can contribute to autism as their ingredients and childhood immunisation schedules have not been adequately studied.
But extensive research has found no relationship between vaccines and autism. A World Health Organization review published in September 2026 examined studies published between 2010 and August 2025 and defied this claim.
Also read: World Immunization Day: Former CDC Advisor Explains Why The Vaccine-Autism Myth Is So Hard To Debunk
Kennedy has also questioned the safety of the combined measles, mumps and rubella (MMR) vaccine, supporting President Trump's proposal to separate the three vaccines.
In August 2026, he defended an executive order calling to pursue the option of separating the combination vaccine. He also cited research that he said supported the move.
However, vaccine experts have said there is no evidence that splitting the MMR vaccine makes it safer or reduces autism risk. In fact, they said that separating the shots could also mean more injections and delays in completing vaccination, leaving children vulnerable to infection.
Kennedy has advocated for raw, unpasteurised milk, claiming it is healthier than pasteurised milk and that it is better for gut health. However, the US Food and Drug Administration (FDA) says these benefits have not been scientifically backed.
Pasteurisation involves heating milk to eliminate harmful microorganisms. Raw milk can carry pathogens like E. coli, Salmonella, Listeria and Campylobacter, which can cause serious foodborne illness.
The FDA has documented outbreaks due to contaminated raw milk, including illnesses involving kidney failure and pregnancy complications.
Kennedy has called fluoride an industrial waste product and pushed for its removal from public water supplies.
There is a legitimate scientific discussion about fluoride exposure at high levels. A US National Toxicology Program review found that higher fluoride exposures, especially those above recommended drinking-water levels, were linked to lower IQ scores in children.
But it does not prove that fluoride at the levels used in community water fluoridation produces the same effects.
The US Centers for Disease Control and Prevention (CDC) continues to support community water fluoridation at the recommended concentration of 0.7 milligrams per litre. It considers this an effective way to prevent tooth decay.
During the COVID-19 pandemic, Kennedy argued that more use of ivermectin and hydroxychloroquine could have reduced deaths. But subsequent clinical trials and systematic reviews did not establish that either drug improved any outcome for people with COVID-19.
A 2025 systematic review and network meta-analysis published in the BMJ, covering hundreds of trials, found that neither ivermectin nor hydroxychloroquine reduced hospital admissions or mortality compared to routine treatments in people with COVID-19.
Kennedy has also spoken against acetaminophen, sold under the brand name Tylenol, and its role in autism risk when used during pregnancy.
It attracted scientific attention as some studies observed links between prenatal acetaminophen exposure and neurodevelopmental conditions. But evidence is still inconclusive.
In September 2025, the FDA acknowledged that evidence suggesting a possible link but explicitly stated that it had not been established thoroughly.
Kennedy has also claimed that circumcision can cause autism, which is, too, not supported by science.
As part of his Make America Healthy Again agenda, Kennedy criticised seed oils, including soybean, corn, canola and sunflower oils, suggesting that they cause inflammation and chronic disease. He also promoted alternatives like beef tallow.
But evidence does not support that seed oils are inherently harmful. These oils contain unsaturated fats and replacing saturated fats with polyunsaturated fats can help lower LDL cholesterol, which is a risk factor for cardiovascular disease.
The American Heart Association's 2026 dietary guidance supports replacing sources of saturated fat, including butter and beef tallow, with oils rich in unsaturated fats.
Kennedy has warned that electromagnetic radiation from wireless devices could damage mitochondria, disrupt biological processes and increase cancer risk.
Cellphones emit radiofrequency radiation, which is non-ionising and does not have enough energy to directly damage DNA in the way that ionising radiation, like X-rays, can.
The US National Cancer Institute says that evidence to date suggests cellphone use does not cause brain or other cancers in humans.
Kennedy has repeatedly questioned whether childhood vaccines have been tested for safety sufficiently, arguing that many have not been evaluated in placebo-controlled trials. This claim can be misleading as it deems only one type of trial as acceptable and safe.
Vaccines undergo clinical testing before approval. Their safety and effectiveness are evaluated through different study designs. Depending on the vaccine, trials may compare a new vaccine with an existing vaccine or another appropriate control rather than a placebo.
In a 2021 interview, Kennedy suggested that Black Americans should follow a different vaccination schedule from white Americans, claiming that Black people had stronger immune systems and could be more vulnerable to vaccine’s side effects.
Medical experts defied the argument as scientifically unreliable. There is no established basis for assigning vaccination schedules according to race.
Vaccine recommendations are based on factors like age, medical history, immune status, exposure risk and other clinical considerations.
Credit: Mark Kelly/X
Actress Olivia Munn has joined US Senator Mark Kelly to push for legislation that would make breast cancer risk assessments a routine part of healthcare for American women, helping them understand their individual risk and access appropriate screening.
Together, they have introduced the Know Your Risk Act, which aims to expand access to validated breast cancer risk assessment tools and integrate them into routine healthcare.
Munn, who was diagnosed with breast cancer in 2023, said a risk assessment prompted her doctor to recommend further testing despite her having a normal mammogram and negative genetic testing. The additional tests detected an aggressive cancer early.
"Had it not been for that assessment, my breast cancer may not have been identified when it was," Munn said while announcing the legislation alongside Kelly.
Also read: World Breast Cancer Day 2026: Life After Breast Cancer, The Fear No One Sees
Announcing the legislation outside the US Capitol, Kelly said existing breast cancer risk assessment tools are not being used widely enough, leaving many women unaware of their individual risk.
"These tools already exist, but too often doctors aren't using them and women don't know that they're available," Kelly said.
The Democratic senator from Arizona said the Act would make breast cancer risk assessments a routine part of healthcare, helping women and their doctors understand individual risk and determine appropriate screening.
"Women shouldn't have to ask for these assessments. They should be part of regular care like getting a blood pressure reading taken," Kelly said.
He added that the legislation had bipartisan support, with lawmakers recognizing the importance of expanding access to early detection.
Munn's experience highlights why individual risk assessments matter, particularly when standard screening and genetic testing may not identify a woman's breast cancer risk.
Despite having a normal mammogram and negative genetic testing, her risk assessment prompted further investigations that led to her diagnosis.
She said the experience motivated her to work with Kelly to ensure other women have access to similar assessments.
According to the World Health Organization (WHO), breast cancer caused an estimated 694,000 deaths worldwide in 2024. It was the most commonly diagnosed cancer among women in 164 of 186 countries.
In the US, breast cancer is the second leading cause of cancer death among women, according to the Centers for Disease Control and Prevention (CDC).
Early detection can significantly improve breast cancer outcomes. According to the National Cancer Institute, the five-year relative survival rate for women with localized breast cancer is more than 99%.
During the announcement, a representative of breast cancer organization Susan G. Komen highlighted the difference between detecting the disease before and after it spreads, noting that survival rates can fall to around 30% when breast cancer is diagnosed at a distant stage.
The representative also pointed to the rising number of diagnoses among women under 50, many of whom may not consider themselves at risk.
The Know Your Risk Act seeks to address this gap by expanding access to validated risk assessment tools, helping women and their doctors better understand individual risk and make informed decisions about screening.
Credit: AI
New rules to govern organ donation in the United States went into effect from Wednesday, November 18, 2026. According to the latest safeguards, before organ recovery can begin, a minimum five-minute observation period is mandatory after a patient's circulation stops.
The rules come amid concerns about patients showing signs of neurological activity during the organ recovery procedure and also whether it had been adequately confirmed that the patient died.
The rules apply to donation after circulatory death (DCD), a process in which organs may be recovered after a patient's heart and circulation have stopped. They are not applicable to every form of organ donation.
The new requirements were developed under the Health Resources and Services Administration (HRSA) and the Organ Procurement and Transplantation Network (OPTN). They include additional safeguards, including stronger and clearer neurological checks, a formal process to pause donation when safety concerns arise, and more transparent communication with families.
The changes come after HRSA probed into organ procurement systems. In July 2025, the US Department of Health and Human Services said it had examined 351 cases in which organ donation had been authorised but ultimately did not proceed.
The review found concerning details in 103 cases, including 73 patients who showed neurological signs that were considered incompatible with organ donation. It also found that at least 28 patients may not have been deceased when organ recovery was initiated.
On a wider front, the investigation sparked questions about the inadequacy of neurological assessments, coordination between hospitals and organ procurement organisations, and the documentation of death. HRSA subsequently directed the OPTN to strengthen safeguards across the donation process.
Also read: Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI
Under the new policy, an observation period of at least five minutes must pass after circulation has ceased before organ recovery can begin.
The aim is to confirm that the heart does not restart spontaneously, a rare phenomenon called autoresuscitation. It is also sometimes called the Lazarus phenomenon.
In DCD, a patient's life-saving treatment is stopped after a decision made by the patient or their legally authorised representative in consultation with the doctors.
If the patient dies after their heart and circulation stop, organ donation may proceed after death has been determined with complete certainty and the mandatory observation period completed.
Also read: Life At Any Cost: Why We Fight To Prolong Life But Question The Idea To Ease Death?
Apart from the five-minute observation period, the new also include:
© $2026 Times Horizon Private Limited